Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

Mocroft A(2003)Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 22-29

Ledergerber B(2009)Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells J Infect Dis 200 1212-1215

Katlama C(2010)Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection J Infect Dis 201 1788-1795

Kirk O(2009)HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy PLoS One 4 e7658-1483

Reiss P(2011)Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy J Infect Dis 203 1474-200

D’ Arminio Monforte A(2012)Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients J Clin Virol 53 195-6

Knysz B(2010)Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation Top HIV Med 18 2-291

Dietrich M(2008)Regulatory T, cells and HIV-1 infection Viral Immunol 21 285-1405

Phillips AN(2002)Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clin Infect Dis 34 1396-2174

Lundgren JD(2006)Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review AIDS 20 2165-1230

Mocroft A(2003)Decline in the AIDS and death rates in the EuroSIDA study: an observational study Lancet 362 22-29

Ledergerber B(2009)Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells J Infect Dis 200 1212-1215

Katlama C(2010)Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection J Infect Dis 201 1788-1795

Kirk O(2009)HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy PLoS One 4 e7658-1483

Reiss P(2011)Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy J Infect Dis 203 1474-200

D’ Arminio Monforte A(2012)Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients J Clin Virol 53 195-6

Knysz B(2010)Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation Top HIV Med 18 2-291

Dietrich M(2008)Regulatory T, cells and HIV-1 infection Viral Immunol 21 285-1405

Phillips AN(2002)Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy Clin Infect Dis 34 1396-2174

Lundgren JD(2006)Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review AIDS 20 2165-1230